Dai Wang, Ph.D.
Affiliations: | 2000 | Cornell University, Ithaca, NY, United States |
Area:
Veterinary Science Biology, Microbiology BiologyGoogle:
"Dai Wang"Parents
Sign in to add mentor| Colin R. Parrish | grad student | 2000 | Cornell | |
| (Nonstructural protein 2 and cellular factors in canine and feline parvovirus infection.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Valencia SM, Rochat E, Harnois MJ, et al. (2023) Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection. Npj Vaccines. 8: 154 |
| He L, Taylor S, Costa C, et al. (2022) Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L. Viruses. 14 |
| Li F, Freed D, Heidecker G, et al. (2022) A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments. Vaccine |
| Su H, Ye X, Freed DC, et al. (2020) A potent bispecific neutralizing antibody targeting glycoprotein B and the gH/gL/pUL128/130/131 complex of human cytomegalovirus. Antimicrobial Agents and Chemotherapy |
| Jenks JA, Nelson CS, Roark HK, et al. (2020) Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans. Science Translational Medicine. 12 |
| Goodwin ML, Webster HS, Wang HY, et al. (2020) Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection. Virology. 548: 182-191 |
| Ye X, Su H, Wrapp D, et al. (2020) Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step. Plos Pathogens. 16: e1008736 |
| Plotkin SA, Wang D, Oualim A, et al. (2020) The Status of Vaccine Development Against the Human Cytomegalovirus. The Journal of Infectious Diseases. 221: S113-S122 |
| Tabata T, Petitt M, Fang-Hoover J, et al. (2019) Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas. Vaccines. 7 |
| Adler SP, Lewis N, Conlon A, et al. (2019) Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects. The Journal of Infectious Diseases. 220: 411-419 |